Wang Guoqiang, He Qingzhong, Feng Chong, Liu Yang, Deng Zengqin, Qi Xiaoxuan, Wu Wei, Mei Pinchao, Chen Zhongzhou
From the State Key Laboratory of Agrobiotechnology, China Agricultural University, Beijing 100193 and.
the Department of Biochemistry and Molecular Biology, National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China.
J Biol Chem. 2014 Oct 3;289(40):27924-36. doi: 10.1074/jbc.M114.590505. Epub 2014 Aug 13.
ALKBH7 is the mitochondrial AlkB family member that is required for alkylation- and oxidation-induced programmed necrosis. In contrast to the protective role of other AlkB family members after suffering alkylation-induced DNA damage, ALKBH7 triggers the collapse of mitochondrial membrane potential and promotes cell death. Moreover, genetic ablation of mouse Alkbh7 dramatically increases body weight and fat mass. Here, we present crystal structures of human ALKBH7 in complex with Mn(II) and α-ketoglutarate at 1.35 Å or N-oxalylglycine at 2.0 Å resolution. ALKBH7 possesses the conserved double-stranded β-helix fold that coordinates a catalytically active iron by a conserved HX(D/E) … Xn … H motif. Self-hydroxylation of Leu-110 was observed, indicating that ALKBH7 has the potential to catalyze hydroxylation of its substrate. Unlike other AlkB family members whose substrates are DNA or RNA, ALKBH7 is devoid of the "nucleotide recognition lid" which is essential for binding nucleobases, and thus exhibits a solvent-exposed active site; two loops between β-strands β6 and β7 and between β9 and β10 create a special outer wall of the minor β-sheet of the double-stranded β-helix and form a negatively charged groove. These distinct features suggest that ALKBH7 may act on protein substrate rather than nucleic acids. Taken together, our findings provide a structural basis for understanding the distinct function of ALKBH7 in the AlkB family and offer a foundation for drug design in treating cell death-related diseases and metabolic diseases.
ALKBH7是线粒体AlkB家族成员,是烷基化和氧化诱导的程序性坏死所必需的。与其他AlkB家族成员在遭受烷基化诱导的DNA损伤后的保护作用相反,ALKBH7会引发线粒体膜电位的崩溃并促进细胞死亡。此外,小鼠Alkbh7的基因缺失会显著增加体重和脂肪量。在此,我们展示了人ALKBH7与Mn(II)和α-酮戊二酸形成复合物的晶体结构,分辨率为1.35 Å,或与N-草酰甘氨酸形成复合物的晶体结构,分辨率为2.0 Å。ALKBH7具有保守的双链β-螺旋结构,通过保守的HX(D/E)…Xn…H基序配位一个具有催化活性的铁。观察到Leu-110的自羟基化,表明ALKBH7有催化其底物羟基化的潜力。与其他底物为DNA或RNA的AlkB家族成员不同,ALKBH7没有对结合核碱基至关重要的“核苷酸识别盖”,因此表现出一个暴露于溶剂的活性位点;β链β6和β7之间以及β9和β10之间的两个环形成了双链β-螺旋小β-片层的特殊外壁,并形成一个带负电荷的凹槽。这些独特特征表明ALKBH7可能作用于蛋白质底物而非核酸。综上所述,我们的研究结果为理解ALKBH7在AlkB家族中的独特功能提供了结构基础,并为治疗细胞死亡相关疾病和代谢疾病的药物设计提供了基础。